ZFSW
Cancer vaccine developer
ZFSW, founded in July, 1995 and headquartered in Chongqing, is an anti-cancer vaccine developer. The founder is Jiang Rensheng. Listed on the SZSE on September 28, 2010, the company's major shareholders are Jiang Rensheng, Jiang Lingfeng and Wu Guanjiang. Rivals that have direct and indirect competition with ZFSW include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
Shenzhen textile A: the order of line 7 is full, and the production line speed is climbing
Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis
‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’
Jan 30, 2023 02:13 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Half day main capital net inflow of power equipment, non bank finance, selling banks, etc
Monitoring of main funds of star mine: Top 10 list of early trading
Pharmaceutical and biological stocks fell sharply in early trading
US Senate committee to investigate the role of cryptocurrency in cyber crime
A breakthrough in cell therapy of solid tumor by Zhifei biological joint stock company